Related Experiment Video

Updated: May 17, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Immunotherapy Utilization and Survival in Metastatic Merkel Cell Carcinoma with Known vs Unknown Primary Tumors: A

Hue T T Tran1, Thuy M Tran2, Duc V Le1

  • 1Department of Dermatology, Mayo Clinic, Rochester, Minnesota; Hanoi Medical University, Hanoi, Viet Nam; National Hospital of Dermatology and Venereology, Hanoi, Vietnam.

Journal of the American Academy of Dermatology
|May 15, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Merkel cell carcinomaNCDBimmunotherapyknown primaryoverall survivalunknown primary

More Related Videos

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.